Bright Minds Biosciences Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Bright Minds Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $168.12. The average 1-year stock price forecast is 143.65% higher than the current stock price, while the lowest is $142.78 (+106.93%) and the highest is $217.94 (+215.86%).

Price Target: $168.12 (+143.65%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$142.78	$168.12	$143.64	$217.94
Change	+106.93%	+143.65%	+108.17%	+215.86%

Analyst Ratings

The average analyst rating for Bright Minds Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	6	6	5	6	6	6
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	6	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick Trucchio H.C. Wainwright	H.C. Wainwright	Buy Reiterates $145	Buy	Reiterates	$145	+110.14%	Jun 1, 2026
Joseph Thome TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 21, 2026
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Reiterates $190 → $220	Buy	Reiterates	$190 → $220	+218.84%	May 20, 2026
Andrew Tsai Jefferies	Jefferies	Buy Initiates $145	Buy	Initiates	$145	+110.14%	Apr 12, 2026
Thomas Shrader BTIG	BTIG	Buy Maintains $147	Buy	Maintains	$147	+113.04%	Mar 30, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

33.61M

EPS This Year

-6.05

from -1.78

EPS Next Year

-12.09

from -6.05

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026
Revenue	-	-	-	-	-	-
Operating Income	-8.62M	-14.73M	-7.20M	-2.63M	-13.61M	-71.69M
Net Income	-8.65M	-14.96M	-7.37M	-2.80M	-12.23M	-62.69M
EPS	-	-	-	-	-1.78	-6.05
Free Cash Flow	-3.85M	-7.58M	-4.22M	-688.05K	-4.60M	-73.30M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-6.05
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-